论文部分内容阅读
进入九十年代以来,随着我国社会主义市场经济的逐步建立,长期实行的医、药合业,以药养医模式的弊端也开始显露。对此,近年来一批有识之士关于医、药分业管理的呼声颇高,已引起了国家医药管理部门的极大关注。本文就医、药合业所反映的问题和医、药分业的基本对策作一思考。一、医、药合业的历史作用从历史唯物主义的观点看,在我国长期实行的医、药合业的模式,既是特定历史条件的产物,也发挥出了特定的历史作用。
Since the 1990s, with the gradual establishment of China’s socialist market economy, the long-established medical and pharmaceutical industry has begun to expose the drawbacks of its drug-based medical care model. In response to this, in recent years, a group of people of insight have spoken loudly about the management of medical and pharmaceutical industries, which has aroused great concern from the state pharmaceutical administration. This article considers the problems reflected in the medical and pharmaceutical industries and the basic countermeasures for the separation of medicine and medicine. I. The historical role of the medical and pharmaceutical industry From the viewpoint of historical materialism, the model of medical and pharmaceutical cooperation that has long been implemented in China is both a product of specific historical conditions and has played a specific historical role.